6-shogaol was found to inhibit the secretion of the angiogenic inducers vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) by blocking the activation of NF-kB in ovarian cancer cells, thereby inhibiting angiogenesis [83]. Here, CXCL8 is linked to ovarian carcinoma.